Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT05795439 · Physicians Committee for Responsible Medicine

The CARING Study: Creating and Restoring Health Through Nutrition Guidance

What this study is about

The CARING study assesses the health benefits of nutrition education for Blue Cross Blue Shield subscribers, as well as potential healthcare cost savings to subscribers and the insurance company.

View original scientific description

The CARING study assesses the health benefits of nutrition education for Blue Cross Blue Shield subscribers, as well as potential healthcare cost savings to subscribers and the insurance company.

Interventions

BEHAVIORAL

Low-fat, vegan diet

The intervention diet consists of whole grains, vegetables, legumes, and fruits, with no restriction on energy intake. Participants will also be guided to favor foods with a low glycemic index. Animal products and added oils will be excluded. The diet is designed to derive approximately 10% of energy from fat, approximately 10-15% of energy from protein, and the remainder from mostly complex carbohydrates. The diet will also provide approximately 40 g of fiber per day.

Primary outcome measures

Medical Utilization

Time frame: 16 weeks, 1 year, and 2 years

This study will assess the effectiveness of a series of plant-based nutrition classes on health changes, measured by combined subscriber and insurance total cost of care (healthcare and health benefits).

Body Weight

Time frame: 16 weeks, 1 year, and 2 years

This study will assess the association of attending a series of plant-based nutrition classes with pre-post changes in body weight.

Plasma Lipid Concentrations

Time frame: 16 weeks, Every 6 months during the 2-year follow-up period

This study will assess the association of attending a series of plant-based nutrition classes with pre-post changes in plasma lipid concentrations.

HbA1C

Time frame: 16 weeks, Every 6 months during the 2-year follow-up period

This study will assess the association of attending a series of plant-based nutrition classes on with pre-post changes in glycemic control in individuals with type 2 diabetes as assessed by hemoglobic A1c (HbA1c) and use of medications.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Blue Cross Blue Shield subscriber continuously enrolled for the prior 12 months
  • Male or female
  • Age at least 18 years
  • Have a diagnosis of type 2 diabetes
  • Ability and willingness to participate in all components of the study, including:
  • Following a plant-based diet for the initial 16 weeks of the study;
  • Attending weekly online classes for the initial 16 weeks of the study; and
  • Keeping physical activity level consistent throughout the initial 16 weeks of the study.

Exclusion criteria

  • Diabetes mellitus type 1 or history of any endocrine condition that would affect body weight, such as a pituitary abnormality or Cushing's syndrome
  • Smoking during the past six months
  • Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
  • Current or unresolved past drug abuse
  • Recently gave birth, pregnant, or plans to become pregnant before or during the study period
  • Unstable medical or psychiatric status
  • Cancer diagnosis
  • Chronic kidney disease, stage 4 or 5
  • Evidence of an eating disorder
  • Lack of English fluency
  • Bariatric surgery in the last 6 months
  • Institutional custodial care
  • End of life
  • Palliative Care
  • Actively engaged in specific BCBSM diabetes programs and case management programs

Where

  • Washington D.C., District of Columbia

Collaborators

Blue Cross Blue Shield, Mayo Clinic

Related conditions & keywords

Type2diabetesType 2 Diabetes Treated With InsulinDiabetesType2InsulinA1C

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Apr 13, 2026 · Source of record for eligibility and locations

📊
1 of 700 participants interested
0% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Washington D.C.

District of Columbia

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Pulmonary Embolism Trials by City

Browse all pulmonary embolism clinical trials in these cities — not just this study.

Looking for Type2diabetes Treatment in Washington D.C.?

Join others in District of Columbia exploring innovative treatment options through clinical research

Type2diabetes Treatment Options in Washington D.C., District of Columbia

If you're searching for Type2diabetes treatment in Washington D.C., participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Washington D.C. and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Type2diabetes. All study-related care is provided at no cost to participants.

Local Sites
1 locations in District of Columbia
Now Enrolling
Up to 700 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Type2diabetes?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Type2diabetes

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Type2diabetes Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT05795439. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.